MEDICINAL AGENTS CONTAINING N-SULFAMOYL-N'-ARYLPIPERAZINES MEANT FOR PREVENTING OR TREATING OBESITY AND RELATED CONDITIONS Russian patent published in 2010 - IPC C07D295/26 C07D401/04 C07D403/04 C07D405/04 A61K31/495 A61K31/496 A61P3/04 A61P3/06 A61P3/10 A61P9/00 

FIELD: chemistry.

SUBSTANCE: invention relates to use of existing and novel N-sulfamoyl- N'-arylpiperazines and their physiologically compatible acid-addition salts of formula I , where Ar denotes a monocyclic or bicyclic C₆-C₁₀aryl in which ring carbon atoms are optionally substituted with 1-3 nitrogen or oxygen atoms, and/or where the C₆-C₁₀aryl ring system optionally contains 3-5 double bonds, and/or where the C₆-C₁₀aryl ring system is optionally substituted with 1 or 2 substitutes which can be identical or different and which can be selected from a group containing halogen, trifluoromethyl, cyano group, nitro group, C₁-C₄alkyl, C₁-C₄alkoxy group, C₁-C₄alkylsulfonyl; and two oxygen atoms which are bonded to two neighbouring carbon atoms of the C₆-C₁₀aryl ring system and are bonded by a C₁-C₂alkylene bridge; or where the C₆-C₁₀aryl ring system is substituted with phenyl which can optionally be substituted in the phenyl ring by one substitute which can be selected from a group containing halogen; for preventing or treating obesity and related diseases.

EFFECT: design of a method of obtaining the said compounds and a pharmaceutical composition based on the said compounds.

25 cl, 9 tbl, 5 ex